Axelspace Secures Japan Ministry of Defense Satellite Constellation Project
Business Wire India Axelspace Corporation (“Axelspace”), a leading developer and operator of microsatellites dedicated to realizing […]
Kyusyu VolcanoTourism Council: Launch of New Website for Travel Trade Partners
Business Wire India ~Feel the pulse of the Earth on a journey to Kyushu—where people […]
Sai Life Sciences to Recruit 700+ Professionals in FY27
Business Wire India Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading […]
Rimini Street Announces Fiscal Fourth Quarter and Annual 2025 Financial and Operating Results
Business Wire India Fourth Quarter and Full Year 2025 Financial Highlights Include: Remaining Performance Obligations […]
NIIT Ltd. Partners with Sporting Club Delhi as Associate Sponsor and Official Skilling Partner for Indian Super League Season 12
Business Wire India Expands NIIT’s visibility among India’s large and engaged football audience Reinforces its relevance […]
Taiwan Showcases ‘Non-Stop’ Tourism Appeal in India, Targets India’s High-Value Travellers
Business Wire India Seeking a larger share of India’s fast-growing outbound travel market, Taiwan Tourism Administration […]
Unveiling NVIDIA Solution Center: Grid Dynamics’ Family of AI Solutions to Cut Costs for Retail and Manufacturing
Business Wire India Key Takeaways: Enables enterprises to replace high-cost and recurring SaaS licensing fees […]
Balmain Beauty Introduces Destin de Balmain: A New Prestige Fragrance
Business Wire India Balmain Beauty unveils Destin de Balmain, its debut prestige fragrance. The new feminine […]
GVRP and Yurogen Biosystems Announce Partnership to Enhance Biologics Drug Discovery in India
Business Wire India GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, […]
Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
Business Wire India Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients […]